Summarized by Masters of Longevity from Longevity Docs News.
Two lower weekly CagriSema doses cut weight by about 21% versus placebo.

Key Takeaways
- Two lower doses produced about 21% mean weight loss.
- The trial excluded people with diabetes and was mostly women.
- Doses were not compared head-to-head, so equivalence remains unproven.



